An Update on the Controversies in Anemia Management in Chronic Kidney Disease: Lessons Learned and Lost

Background. Erythropoietin deficiency and anemia occur in Chronic Kidney Disease (CKD) and may be treated with Erythropoietin Stimulating Agents (ESAs). The optimal hemoglobin, in non-End Stage Renal Disease CKD, is controversial. Methods. We review three recent randomized trials in anemia in CKD: C...

Descripción completa

Detalles Bibliográficos
Autores principales: Teehan, Geoffrey, Benz, Robert L.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085324/
https://www.ncbi.nlm.nih.gov/pubmed/21541213
http://dx.doi.org/10.1155/2011/623673

Ejemplares similares

Ejemplares similares